Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Atkins

Showing results (81-90 of 493) with videos related to

Pageof 50
Sort By:
Psychology Research and Behavior Management|May 22, 2015
A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disordersMarco A Grados, Elizabeth B Atkins, Gabriela I Kovacikova, et al.
Cytokine|October 1, 1995
Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapyH Tilg, M B Atkins, C A Dinarello, et al.
The New England Journal of Medicine|April 5, 1990
An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapyM S Klempner, R Noring, J W Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2004
Standardization and quantification of radionuclide solid gastric-emptying studiesHarvey A Ziessman, Frederic H Fahey, Frank B Atkins, et al.
Cancer Research|February 3, 2006
The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cellsDavid J Panka, Wei Wang, Michael B Atkins, et al.
Cureus|May 26, 2026
Heat-Associated Mortality and Emergency Department Utilization in Southern Nevada During 2024: A Retrospective Descriptive AnalysisDeanna Chea, Justin B Atkins, Oscar A Toro Ruilowa, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4B K Lam, K Xu, M B Atkins, et al.
The American Journal of Medicine|June 1, 1992
Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancyE M Massarotti, N Y Liu, J Mier, et al.
Journal of Environmental Management|December 28, 2020
Common asset trusts to effectively steward natural capital and ecosystem services at multiple scalesRobert Costanza, Paul W B Atkins, Marcello Hernandez-Blanco, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 14, 2020
Normal development in Ambystoma mexicanum: A complementary staging table for the skull based on Alizarin red S stainingJade B Atkins, Laurent Houle, Alanna S Cantelon, et al.
Pageof 50

Showing results (81-90 of 493) with videos related to

Sort By:
Pageof 50
Psychology Research and Behavior Management|May 22, 2015
A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disordersMarco A Grados, Elizabeth B Atkins, Gabriela I Kovacikova, et al.
Cytokine|October 1, 1995
Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapyH Tilg, M B Atkins, C A Dinarello, et al.
The New England Journal of Medicine|April 5, 1990
An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapyM S Klempner, R Noring, J W Mier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2004
Standardization and quantification of radionuclide solid gastric-emptying studiesHarvey A Ziessman, Frederic H Fahey, Frank B Atkins, et al.
Cancer Research|February 3, 2006
The Raf inhibitor BAY 43-9006 (Sorafenib) induces caspase-independent apoptosis in melanoma cellsDavid J Panka, Wei Wang, Michael B Atkins, et al.
Cureus|May 26, 2026
Heat-Associated Mortality and Emergency Department Utilization in Southern Nevada During 2024: A Retrospective Descriptive AnalysisDeanna Chea, Justin B Atkins, Oscar A Toro Ruilowa, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1992
Leukotriene C4 uses a probenecid-sensitive export carrier that does not recognize leukotriene B4B K Lam, K Xu, M B Atkins, et al.
The American Journal of Medicine|June 1, 1992
Chronic inflammatory arthritis after treatment with high-dose interleukin-2 for malignancyE M Massarotti, N Y Liu, J Mier, et al.
Journal of Environmental Management|December 28, 2020
Common asset trusts to effectively steward natural capital and ecosystem services at multiple scalesRobert Costanza, Paul W B Atkins, Marcello Hernandez-Blanco, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|January 14, 2020
Normal development in Ambystoma mexicanum: A complementary staging table for the skull based on Alizarin red S stainingJade B Atkins, Laurent Houle, Alanna S Cantelon, et al.
Pageof 50